DESIGN, DEVELOPMENT AND EVALUATION OF MICONAZOLE NITRATE TOPICAL GEL FOR FUNGAL INFECTIONS
HTML Full TextDESIGN, DEVELOPMENT AND EVALUATION OF MICONAZOLE NITRATE TOPICAL GEL FOR FUNGAL INFECTIONS
- Nagalakshmi,* Radhika Ramaswamy, Renuga, Sowjanya, Premalatha, Vijayanjani and S. Shanmuganathan
Department of Pharmaceutics, Faculty of Pharmacy, Sri Ramachandra University, Porur, Chennai-600116, Tamil Nadu, India.
ABSTRACT: In this investigation, Miconazole Nitrate topical gels were designed by employing various bioadhesive polymers like polyacrylates (carbopol 940), cellulose derivatives (hydroxyl propyl methyl cellulose and sodium carboxy methyl cellulose) and natural polymers (sodium alginate) alone and in combination. The prepared gels were also characterized for different parameters like visual appearance, pH, consistency, rheological studies, drug content, in vitro release studies, stability studies and antifungal activity. From the results it was found that all the formulations were free of gritty particles and were found to be uniform in consistency. The values of pH were within the range of the skin pH that is in between 5.9 and 6.8, which indicates these gels cannot cause any local irritation to the skin surface. The consistencies of the gels were found to be excellent. The viscosity values of the gel increased in the following manner: carbopol and HPMC >carbopol>carbopol and SCMC >carbopol and sodium alginate > Sodium alginate >SCMC: indicating that carbopol in combination with HPMC was found to be the most viscous gel when compared to the others. The drug content was found to be uniform among various batches prepared and were in the range from 98.78±0.14 to 99.88±0.1%. The release of drug from all the formulations at the end of 8 hours study ranged from 68.78±0.42 to 99.88±0.05%. Gels containing carbopol 940 and HPMC and carbopol 940 alone released the drug at a sustained manner when compared to the gels containing SCMC and sodium alginate alone which released at a faster rate within 8 hours. The antifungal assay revealed that the gels containing carbopol 940 and HPMC in combination and carbopol 940 alone showed the maximum zone of inhibition values of about 15mm and 14mm respectively upto 72 hours. They possessed the maximum antifungal activity. The stability studies revealed good physical stability for all formulated preparations.
Keywords: |
Miconazole Nitrate gels, Carbopol 940, Hydroxy propyl methyl cellulose, Sodium carboxy methyl cellulose, Sodium alginate, topical
INTRODUCTION: Drug administration through topical is a localized system of delivery of drug anywhere in the body through ophthalmic, rectal, vaginal and the skin as topical routes. Skin is one of the most readily accessible organs on the human body for topical administration and is the main route of topical drug delivery.1
Gels which are made with water are termed as hydrogels while that with an organic liquid are termed as organogels. Hydrogels include the composition of water- soluble materials such as cellulose derivatives and natural gums.
These pseudohydrogels swell to a great extent and the consitutuent molecules dissolve from the surface of the matrix. Drug molecules tend to release through the spaces in the network and also by degradation as well as dissolution of the matrix. Miconazole Nitrate, an antifungal agent is often prescribed for the treatment of various topical fungal infections such as Candidiasis, Coccidio idomycosis, Crypto coccosis, Para coccidio idomycosis, and infections due to Pseudeli escheria. The drug undergoes substantial first pass metabolism and only half the amount of it is bioavailable systemically. To avoid this, delivery of Miconazole Nitrate through skin delivers the potential advantage of bypassing the hepato-gastro first pass metabolism associated with oral administration.2
Although the gel formulation of Miconazole Nitrate seems to be highly useful, there is a lack of literature on the present work. Therefore in this present work it was planned to formulate and evaluate Miconazole Nitrate gels Using various bioadhesive polymers such as cellulose derivatives, sodium alginate and polyacrylates.
MATERIALS AND METHODS:
Materials:
Miconazole Nitrate was obtained as a gift sample from Fourrts India Limited, Chennai, Carbopol 940 (Himedia Laboratories, Lobachemie), Sodium alginate (Loba Chemie), Hydroxyl propyl methyl cellulose (Loba Chemie), Sodium carboxy methyl cellulose (Merck), Peppermint oil, Methyl paraben (Loba Chemie), Triethanolamine (Rankem), Propylene glycol (Sisco Research Laboratories Pvt. Ltd). All chemicals either of analytical or pharmaceutical grade, were used without further purification.
Method:
Gels were formulated by cold mechanical method described by Schmolka et al. (1972) 7, 8. Stated quantity of polymers (carbopol 940, HPMC, SCMC and sodium alginate) were weighed and was sprinkled on the surface of purified water for 2 hrs. Then continuous stirring was done with the help of a mechanical stirrer so that the polymer gets completely soaked in water. With incessant stirring, triethanolamine was added which acts as a neutralizer to maintain the pH of the gel.
Then the required amount of propylene glycol was added to the gel, which amplifies the penetration, followed by the addition of required quantities of methyl paraben that acts as a preservative. Finally the drug, Miconazole Nitrate was incorporated to the gel with continuous stirring until complete dispersion takes place. Six formulations of the topical gel were prepared by incorporation of various polymers alone and in combination. The prepared gels were packed in wide mouthed containers and were kept in dark and cool place.3 (Refer Table 1).
TABLE 1: PREPARATION OF VARIOUS TOPICAL GELS
Ingredients | F1(gm) | F2(gm) | F3(gm) | F4(gm) | F5(gm) | F6(gm) |
Miconazole Nitrate | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 |
Carbopol 9 | 0.5 | 0.5 | - | 1 | 0.5 | - |
HPMC | 0.5 | - | - | - | - | - |
SCMC | - | - | 1 | - | 0.5 | - |
Sodium alginate | - | 0.5 | - | - | - | 1 |
Methyl paraben | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
Propylene glycol | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 |
Triethanolamine | q.s | q.s | q.s | q.s | q.s | q.s |
Distilled water | upto to 30g | upto to 30g | upto to 30g | upto to 30g | upto to 30g | upto to 30g |
EVALUATION OF THE GELS – caps lock:
Visual Appearance:
The prepared gels were visually inspected for clarity, colour and transparency. Smears of gels were prepared on glass slide and observed under the microscope for the presence of any gritty particles.
Surface pH:
An alkaline or acidic formulation can lead to irritation of the skin and hence checking of the surface pH is an important parameter. This test was performed by dipping a digital glass electrode inside the prepared gel.4, 5
Consistency:
To measure the consistency, a cone was attached to a rod at distance of 10cm and it had to be dropped in such a way that it had to fall on the centre of the glass cup with the gel. The penetration of the conefrom the surface of the gel to the tip of the cone inside the gel was measured. The distance travelled by the cone was noted down after 10 seconds.6, 7
Rheological Study:
The viscosities of the various prepared gels were determined by using a Brook Field viscometer (model-DVE) with spindle LV3 at a temperature of about 35±2 ºC.
Drug Content Estimation:
A gram of the gel was weighed accurately and placed inside a tightly closed volumetric flask with 10ml of methanol. Shake the flasks for 10 minutes and then 100ml of the prepared phosphate buffer of pH 7.4 was added and was further subjected to sonication. The absorbance of the above solution was determined using a spectrophotometer at λ max 220nm for its drug content against an appropriate blank solution.2, 8, 9
In-vitro Release Studies:
The in - vitro release studies were done by using open ended cylinders using egg membrane. A glass cylinder was taken which had both its ends open of dimensions 12cm height, 2.1cm outer diameter and 1.5cm inner diameter. The egg membrane was then tied to one end of the open ended glass cylinder compartment. Calculated quantity of gel (1gm) was weighed and was placed in the donor compartment and this apparatus was immersed into a beaker containing 100ml of phosphate buffer of pH 7.4.
The cell was submerged into a depth of 1cm below the surface of the buffer solution in the receptor compartment and was agitated using magnetic stirrers and the temperature needed was maintained at 37±1ºC throughout the study. Aliquots of 5ml sample were withdrawn and were replaced periodically with the fresh buffer pH7.4 solution at intervals of fifteen minutes for the first hour and every half an hour for the next seven hours. The amount of drug released was estimated by using UV spectrophotometer at 220nm.10
The in vitro release of the best two formulations was compared with the marketed product (Daktarin gel- Miconazole Nitrate 20mg/g topical gel) by using the same methods as stated above.
Anti-Fungal Assay:
Preparation of potato Dextrose Broth (PDB):
Antifungal activity of sample was determined by antifungal susceptibility test. Prepare PDB Broth and inoculate the culture. Then it was kept in shaker for a day. The potato dextrose agar was weighed as 3.9g and dissolved in 100ml using distilled water and then1gm of agar was added. Then, the medium was kept for sterilization. After sterilization, the media was poured in to sterile petriplates and were allowed to solidify for twenty minutes. After solidification, the inoculums were spread on the solid plates with sterile swab moistened with the fungal suspension
The disc were placed in PDA plate and 20µl of (20 µl of Different concentrations: 1000µg, 750µg, 500µg, 250µg) each sample were added. each samples were placed in the disc. The plates were kept at room temperature. Then the microbial growth was determined by measuring the diameter of zone of inhibition. After incubation for 18 hours to 72 hours at 25ºC, the fungal growth was observed and the percentage inhibition was measured.
Stability Studies:
All the selected formulations that showed a sustained release were subjected to stability testing as per ICH norms and WHO guidelines at a temperature of about 40±2ºC as well as at room temperature for the same period of time. Samples were withdrawn at the end of every month and analysed for drug content, appearance and pH.5,7
RESULTS AND DISCUSSIONS:
Visual Appearance:
Formulation F1was found to be white in colour and F2 and F6 were light brown in colour due to sodium alginate and F3, F4 and F5 were found to be transparent. All the formulations were free of gritty particles and were found to be uniform in consistency.
Surface pH:
The values of pH were within the range of the skin pH that is in between 5.9 and 6.8, this indicates these gels cannot cause any local irritation to the skin surface. Table 2 shows the surface pH of all the formulations.
Consistency:
The consistency reflects the capacity of the gel to get ejected in uniform and desired quantity when the tube is squeezed. Relation between the consistency in terms of distance travelled by the cone was almost 6 mm in all the developed formulations but was found to be 10 mm in marketed preparation. Consistency is inversely proportional to the distance travelled by falling cone. Refer Table 2.
TABLE 2: VALUES OF pH, CONSISTENCY AND DRUG CONTENT OF THE DEVELOPED GELS
Formulation | pH | Consistency (60sec) | Drug content (%) |
F1 | 6.2 | 6mm | 99.98 |
F2 | 6.4 | 6mm | 99.94 |
F3 | 6.2 | 5mm | 99.95 |
F4 | 5.9 | 6mm | 98.97 |
F5 | 6.8 | 6mm | 98.87 |
F6 | 6.7 | 5mm | 99.78 |
Rheological study:
The viscosity values of the gel increased in the following manner: carbopol and HPMC >carbopol>carbopol and SCMC >carbopol and sodium alginate > Sodium alginate >SCMC: which indicates that carbopol in combination with HPMC was found to be the most viscous gel when compared to the others. Refer Table 3.
TABLE 3: RHEOLOGICAL STUDIES
S. No | Sample | RPM | Centipoise or mPa.s | %torque |
1 | F1 | 0.30.5
0.6 |
2888016710
14450 |
92.489.1
92.5 |
2 | F2 | 1.01.5
2.0 |
79415613
4613 |
84.789.8
98.4 |
3 | F3 | 4.05.0
6.0 |
13031158
1052 |
55.661.8
67.3 |
4 | F4 | 0.30.5
0.6 |
2891018900
13410 |
92.589.9
85.8 |
5 | F5 | 0.30.5
0.6 |
2431015230
12920 |
77.881.2
82.6 |
6 | F6 | 4.05.0
6.0 |
12051099
1072 |
49.852.7
64.9 |
Drug Content Estimation:
The drug content was found to be uniform among various batches prepared and was found to be in the range from 98.78±0.14 to 99.88±0.1%. The drug content determination also showed that the drug was uniformly distributed throughout the gel. Refer Table 2.
In Vitro Release Studies:
The results of in vitro permeation studies of gel formulations across egg membrane are depicted in Table 4, Figure 1 and Table 5, Figure 2. The drug release from all the formulations at the end of 8 hours ranged from 68.78±0.42 to 99.88±0.05%. It can be observed that gels containing carbopol 940 and HPMC and carbopol 940 alone released the drug at a sustained manner when compared to those gels containing SCMC and sodium alginate alone which released at a faster rate within 8 hours. The release from the two best formulations that is F1 and F4 were compared with the release from the marketed formulation. The release profile was found to be sustained for the formulated formulations when compared with the marketed gel.
TABLE 4: IN - VITRO RELEASE STUDIES
Time (mins) | F1 (%) | F2 (%) | F3 (%) | F4 (%) | F5 (%) | F6 (%) |
0 | 0 | 0 | 0 | 0 | 0 | 0 |
15 | 1.52 | 5.25 | 8.99 | 3.46 | 6.42 | 6.23 |
30 | 5.72 | 6.67 | 10.67 | 6.001 | 8.67 | 8.99 |
45 | 7.67 | 9.89 | 13.68 | 8.12 | 12.29 | 10.758 |
60 | 9.99 | 12.457 | 15.76 | 10.75 | 15.83 | 11.59 |
90 | 11.45 | 17.83 | 17.843 | 12.008 | 17.93 | 16.76 |
120 | 12.14 | 20.112 | 21.96 | 13.96 | 19.64 | 19.78 |
150 | 13.21 | 27.74 | 27.83 | 15.53 | 22.18 | 23.42 |
180 | 16.75 | 30.22 | 30.66 | 17.83 | 24.56 | 26.43 |
210 | 20.05 | 39.97 | 39.145 | 19.85 | 30.23 | 30.74 |
240 | 24.56 | 45.39 | 43.674 | 24.28 | 39.64 | 39.53 |
270 | 30.97 | 50.75 | 51.67 | 31.09 | 43.54 | 49.96 |
300 | 35.61 | 56.11 | 59.99 | 38.667 | 50.77 | 56.43 |
330 | 39.88 | 60.12 | 64.66 | 42.21 | 59.9 | 60.58 |
360 | 42.57 | 65.53 | 70.909 | 49.96 | 67.34 | 69.44 |
390 | 49.51 | 71.05 | 77.64 | 58.765 | 74.2 | 75.7 |
420 | 52.01 | 79.99 | 84.623 | 63.98 | 79.96 | 80.394 |
450 | 59.96 | 84.21 | 90.008 | 70.006 | 87.54 | 89.32 |
480 | 68.78 | 90.86 | 99.88 | 77.24 | 94.19 | 96.32 |
FIGURE: 1
TABLE 5: IN - VITRO RELEASE OF F1 AND F4 COMPARED WITH MARKETED GEL
Time (mins) | F1 (%) | F4 (%) | Marketed gel (%) |
0 | 0 | 0 | 0 |
15 | 1.45 | 4.97 | 2.32 |
30 | 4.72 | 6.051 | 8.53 |
45 | 7.657 | 9.12 | 11.65 |
60 | 9.45 | 11.45 | 15.38 |
90 | 11.40 | 12.907 | 18.17 |
120 | 12.14 | 13.916 | 24.89 |
150 | 13.89 | 15.03 | 30.14 |
180 | 16.25 | 17.953 | 41.09 |
210 | 21.05 | 19.85 | 45.36 |
240 | 23.96 | 24.78 | 49.07 |
270 | 30.97 | 31.09 | 52.66 |
300 | 35.61 | 39.126 | 58.96 |
330 | 38.21 | 43.18 | 62.98 |
360 | 43.95 | 53.31 | 69.34 |
390 | 49.91 | 59.809 | 71.97 |
420 | 52.58 | 67.96 | 77.89 |
450 | 60.02 | 72.88 | 85.86 |
480 | 68.06 | 79.567 | 90.12 |
FIGURE: 2
Anti-Fungal Assay:
Table 6 shows the anti-fungal assay values. The studies revealed that the gels containing carbopol 940 and HPMC in combination and carbopol 940 alone showed the maximum zone of inhibition values of about 15mm and 14mm respectively upto 72 hours. They possessed the maximum antifungal activity. The zone of inhibition was found to be 17mm for the marketed formulation.
TABLE 6: ANTI- FUNGAL ASSAY
S. No | Sample | Zone of inhibition(mm) | |||||
1000 µg | 750 µg | 500 µg | 250 µg | Std | Negative Control | ||
1. | F1 | 15 | 14 | 11 | 10 | 14 | - |
2. | F2 | 11 | 10 | 9 | 8 | 14 | - |
3. | F3 | 13 | 12 | 11 | 8 | 14 | - |
4. | F4 | 14 | 13 | 10 | 9 | 14 | - |
5. | F5 | 12 | 10 | 9 | 8 | 14 | - |
6. | F6 | 12 | 12 | 11 | 10 | 14 | - |
7. | Marketed gel | 17 | 16 | 14 | 13 | 14 | - |
Microorganisms: (Candida albicans),
Standard: Amphotericin B (100 mg/ml) 20 µl per disk
Negative control: DMSO
The above figures represent the zone of inhibition for the prepared gels and the marketed gel.
Stability Studies:
There were no significant variations in the drug content, consistency, pH and physical appearance of the gels after storing at the prescribed temperatures as mentioned earlier. All the gels showed promising results. This indicates that the drug was stable even after 3 months of short term storage. Refer Table 7.
TABLE 7: STABILITY STUDY OF VARIOUS DEVELOPED GELS
Sample no. | Months | Appearance | pH | Drug content |
F1 | 0 | Clear | 6.2 | 99.98 |
1 | Clear | 6.2 | 99.95 | |
2 | Clear | 6.1 | 99.90 | |
3 | Clear | 6.1 | 99.86 | |
F4 | 0 | Clear | 5.9 | 98.80 |
1 | Clear | 5.9 | 98.73 | |
2 | Clear | 5.8 | 98.23 | |
3 | Clear | 5.7 | 97.99 |
CONCLUSION: The present work aimed towards developing the topical gel of Miconazole Nitrate for the treatment of Candidiasis using various gelling agents like carbopol 940, HPMC, SCMC, sodium alginate in combination as well as alone. Miconazole Nitrate is an antifungal agent belonging to the imidazole group of drugs. Since oral route causes GI side effects and first pass metabolism there is a decrease in the bioavailability, in order to prevent this disadvantage, gels containing Miconazole Nitrate were prepared. Six formulations of the topical gels (F1, F2, F3, F4, F5 and F6) were prepared using different polymers as mentioned earlier.
Thus it was concluded that Miconazole Nitrate gels can be successfully prepared by using some of the polymers which made the gel bioadhesive, making it stay on the skin for a prolonged period of time and releasing the drug over an sustained manner providing a slow diffusional path length which will be helpful to avoid more fluctuations and also reduces the cost of therapy.
ACKNOWLEDGEMENTS: The authors wish to thank Fourrts India Limited, Chennai for sponsoring the gift sample of Miconazole Nitrate and the Principal, the project guide and all the other faculties of Pharmacy, Sri Ramachandra University, Chennai for permitting to avail the research facilities in the college.
REFERENCES:
- Rashmi M: Topical Gel: A review august vol. 2008; http://www.pharmainfo.net .1-6.
- Afaf A. Ramadan: Formulation and evaluation of bioadhesive gels containing Miconazole Nitrate. Journal of Applied Sciences Research 2008; 4(9).1052-1065.
- Sreenivasa Reddy, S. Mutalik, G. Veerabhadra Rao: Preparation and Evaluation of Minoxidil Gels for Topical Application in Alopecia. Indian Journal of Pharmaceutical Sciences 2006; 68(4), 432-436.
- B. Shah, Y. Yang, M. A. Khan, P. J. Faustino: Molecular Weight Determination for colloidal iron by Taguchi optimized validated gel permeation chromatography. International Journal of Pharmaceutics, 2008; 353, 21-27.
- ICH Harmonized Tripartite Guidelines: Stability Testing of New Drug Substances and Products, ICH Committee, 8, 2003.
- Panda, S. SI, S. Swain, S. Kanungo, R. Gupta: Preparation and Evaluation of Gels from Gum of Moringa Oleifera. Indian Journal of Pharmaceutical Sciences, 2006; 68(6), 777-780.
- D. Shivhare, K. B. Jain, V. B. Mathur, K. P. Bhusari, A. A. Roy: Formulation Development and Evaluation of Diclofenac Sodium Gel using water soluble polymer Polyacrylamide Polymer. Digest Journal of Nanomaterials and Biostructures, 2009; vol 4, no.2, 285-290.
- Mangesh .R. Bhalekar, Varsha Pokharkar, Ashwini Madgulkar, Nilam Patil and Nilkanth Patil: Preparation and Evaluation of Miconazole Nitrate-Loaded Solid Lipid Nanoparticles for Topical Delivery. American Association of Pharmaceutical Sciences 2009; vol. 10, no. 1, 289-296
- Ankur Jain, Piyush Deveda, Naveen Vyas, Jitendra Chauhan, Dr. Sanjay Jain: Development of antifungal emulsion based gel for topical fungal infections. International Journal of Pharma. Research and Development-Online, 2003; issue 12, 18-25.
- D. Gupta, R. S. Gaud: Anti-inflammatory Activity of Tenoxicam Gel on Carrageenan Induced Paw Oedema in Rats. Indian Journal of Pharmaceutical Sciences, 2006; 68(3), 356-359.
- Bharat Parashar, Atul Kabra, Ajay Chandel: Formulation and Evaluation of Gel Containing Miconazole Nitrate an Antifungal Agent. International Journal of Pharma Research & Review, June 2013; 2(6), 18-28.
- Niyaz Basha, Kalyani Prakasam, Divakar Goli: Formulation and evaluation of gel containing fluconazole antifungal agent. International Journal of Drug Development and Research 2011; 3(4), 109-128.
- Sudhir Bharadwaj, G.D Gupta and V.K. Sharma: Topical gel a novel approach for drug delivery, Journal of Chemical, Biological and Physical sciences, 2012; 2(2),856-867.
- Sanap , Mohanta : Journal of Applied Pharmaceutical Science3(01); 2013, 046-054.
- Umme Hani, H.G Shivakumar: Development of Miconazole nitrate Thermosensitive Bioadhesive Vaignal Gel for Vaginal Candidiasis, American Journal of Advanced Drug Delivery1(3); 2013, 358-368
How to cite this article:
Nagalakshmi S, Ramaswamy R, Renuga, Sowjanya, Premalatha, Vijayanjani and Shanmuganathan S: Design, Development and Evaluation of Miconazole Nitrate Topical Gel for Fungal Infections. Int J Pharm Sci Res 2015; 6(3): 1266-72.doi: 10.13040/IJPSR.0975-8232.6(3).1266-72.
All © 2013 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Article Information
43
1266-1272
503
2524
English
Ijpsr
S. Nagalakshmi,* Radhika Ramaswamy, Renuga, Sowjanya, Premalatha, Vijayanjani and S. Shanmuganathan
Department of Pharmaceutics, Faculty of Pharmacy, Sri Ramachandra University, Porur, Chennai-600116, Tamil Nadu, India.
nagalakshmimpharm@gmail.com
29 July, 2014
29 September, 2014
01 December, 2014
DOI: 10.13040/IJPSR.0975-8232.6(3).1266-72
01 March, 2015